Latest Breaking News On - Investigated doses expected - Page 1 : vimarsana.com

EQS-News: Immunic, Inc : Immunic Announces Positive Results from Single and Multiple Ascending Dose Parts of Its Phase 1 Clinical Trial of IMU-856 in Healthy Human Subjects

Issuer: Immunic, Inc. / Key word(s): Study results Immunic Announces Positive Results from Single and Multiple Ascending Dose Parts of Its Phase 1 Clinical Trial of IMU-856 in Healthy Human

New zealandEdna kaplanPaula schwartzJessica breuDaiichi sankyoAndreas muehlerDaniel vittExchange commissionDaiichi sankyo co ltdRx communications groupImmunic incDistribution servicesAnnounces positive resultsMultiple ascending dose partsIts phaseHealthy human subjects

Immunic Announces Positive Results from Single and Multiple Ascending Dose Parts of Its Phase 1 Clinical Trial of IMU-856 in Healthy Human Subjects

Immunic Announces Positive Results from Single and Multiple Ascending Dose Parts of Its Phase 1 Clinical Trial of IMU-856 in Healthy Human Subjects
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

New zealandDaiichi sankyoContactkogs communicationedna kaplanAndreas muehlerDaniel vittExchange commissionDaiichi sankyo co ltdUs ir contactrx communications grouppaula schwartzPrnewswire immunic incImmunic incUnblinded data revealedFavorable safetyPharmacokinetic profileDay multiple dosingInvestigated doses expectedExceed required therapeutic dosing